Michael Eric Lisjak Cyclo Therapeutics, Inc. (CYTH) insider trading activity

CYTH Quotes by TradingView

Michael Eric Lisjak is Chief Regulatory Officer of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 12,400 shares of CYTH, which is worth approximately $7,936. The most recent transaction as insider was on Jan 13, 2021, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.4K
0% 3M change
0% 12M change
Total Value Held $7,936

Michael Eric Lisjak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 13 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 44.64%
12,400 Common Stock
MEL

Michael Eric Lisjak

Chief Regulatory Officer
Old Greenwich, CT

Track Institutional and Insider Activities on CYTH

Follow Cyclo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTH shares.

Notify only if

Insider Trading

Get notified when an Cyclo Therapeutics, Inc. insider buys or sells CYTH shares.

Notify only if

News

Receive news related to Cyclo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYTH